These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


271 related items for PubMed ID: 13402976

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of reserpine and reserpine associated with a psychotonic in some senile psychoses].
    NEGRI F.
    Arch Psicol Neurol Psichiatr; 1956; 17(2-3):441-51. PubMed ID: 13341414
    [No Abstract] [Full Text] [Related]

  • 6. [Recent psychopharmaca].
    MUNKVAD I.
    Manedsskr Prakt Laegegern; 1959 Mar; 37(3):122-31. PubMed ID: 13655813
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Experimental studies with PM 1090; preliminary report.
    EDWALDS RM.
    Int Rec Med Gen Pract Clin; 1956 Jul; 169(7):469-72. PubMed ID: 13331638
    [No Abstract] [Full Text] [Related]

  • 9. A pharmacological report on PM-1090. (A new intravenous convulsant in treatment of psychoses).
    BERG S, ROBBINS ES.
    J Neuropsychiatr; 1959 Jul; 1():32-4. PubMed ID: 13799238
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical experience with meratran; a new stimulant of the central nervous system].
    FABING HB.
    Rev Med Cubana; 1955 Dec; 66(12):923-31. PubMed ID: 13281160
    [No Abstract] [Full Text] [Related]

  • 11. Experimental psychoses which mimic schizophrenia.
    FABING HD.
    Nebr State Med J; 1956 Dec; 41(12):455-9. PubMed ID: 13378541
    [No Abstract] [Full Text] [Related]

  • 12. [Analeptics; use and abuse].
    LUKL P.
    Prakt Lek; 1952 Aug 05; 32(15):330-4. PubMed ID: 12983277
    [No Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of meratran and frenquel on a chronic psychotic population.
    ROSNER BS, FIERMAN LB, KRAMER JF.
    Am J Psychiatry; 1957 May 05; 113(11):993-6. PubMed ID: 13411280
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Initial results concerning the action of a new psychotonic, S 186, in cases of senile intellectual deficiencies].
    SCHWEICH M, CAPRON C, CAPRON H, SANCHEZ F, TIMSIT M.
    Ann Med Psychol (Paris); 1961 Dec 05; 119(2)():977-80. PubMed ID: 13909808
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Observations on the use of centrophenoxine in hospital and ambulant treatment].
    HOUILLON, SALLES, SELIN.
    Ann Med Psychol (Paris); 1963 Jun 05; 2():63-9. PubMed ID: 13955058
    [No Abstract] [Full Text] [Related]

  • 19. [THERAPEUTIC EXPERIENCES WITH VESITAN IN A MIXED GROUP OF PSYCHIATRIC PATIENTS].
    SYDATH W.
    Med Klin; 1964 May 29; 59():902-4. PubMed ID: 14213637
    [No Abstract] [Full Text] [Related]

  • 20. Atypical antipsychotic dosing: the effect of smoking and caffeine.
    de Leon J.
    Psychiatr Serv; 2004 May 29; 55(5):491-3. PubMed ID: 15128955
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.